Publications by authors named "Matthew Byerly"

Claim this Profile
A
A scoping review of the reporting quality of reviews of commercially and publicly available mobile health apps.
Norina Gasteiger, Gill Norman, Rebecca Grainger, Sabine N van der Veer, Lisa McGarrigle, Matthew Byerly

JAMIA Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting quality of published reviews of commercial and publicly available mobile health apps (mHealth app reviews): a scoping review protocol.
Norina Gasteiger, Gill Norman, Rebecca Grainger, Charlotte Eost-Telling, Debra Jones, Matthew Byerly

BMJ Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population.
Jacqueline R Anderson, Michael Killian, Anne Fuller, Jennifer L Hughes, Matthew Byerly

Child Psychiatry Hum Dev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia.
Paul A Nakonezny, Janet C Lindow, T Scott Stroup, Joseph P McEvoy, Marvin S Swartz, Matthew J Byerly

Schizophr Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage.
Elizabeth A Kowalski, Jiang Chen, Amanda Hazy, Lauren E Fritsch, Erwin Kristobal Gudenschwager-Basso, Matthew Byerly

J Neuroinflammation· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention in a Community Population of Adults With Depression Symptoms: Randomized Controlled Trial.
Mark B Schure, Janet C Lindow, John H Greist, Paul A Nakonezny, Sandra J Bailey, Matthew J Byerly

J Med Internet Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1.
Martha Sajatovic, Ruth Ross, Susan N Legacy, Christoph U Correll, John M Kane, Matthew Byerly

Neuropsychiatr Dis Treat· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2.
Martha Sajatovic, Ruth Ross, Susan N Legacy, Matthew Byerly, John M Kane

Neuropsychiatr Dis Treat· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.
Lauren E Ethridge, Stormi P White, Matthew W Mosconi, Jun Wang, Ernest V Pedapati, Matthew J Byerly

Mol Autism· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.
Lauren E Ethridge, Stormi P White, Matthew W Mosconi, Jun Wang, Ernest V Pedapati, Matthew J Byerly

Mol Autism· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.
Jun Wang, Lauren E Ethridge, Matthew W Mosconi, Stormi P White, Devin K Binder, Matthew J Byerly

J Neurodev Disord· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
Robert A Rosenheck, Douglas L Leslie, Kyaw J Sint, Haiqun Lin, Yue Li, Matthew J Byerly

Psychiatr Serv· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Frontotemporal Dementia Presenting With Treatment-Refractory Psychosis and Extreme Violence: Response to Combination of Clozapine, Medroxyprogesterone, and Sertraline.
Manish Kumar Jha, Emily S Lambert, Barbara A Beadles, Brittany Spradling, Rosa Martinez, Matthew Byerly

J Clin Psychopharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS).
Paul A Nakonezny, Taryn L Mayes, Matthew J Byerly, Graham J Emslie

J Psychiatr Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder.
Paul A Nakonezny, David W Morris, Tracy L Greer, Matthew J Byerly, Thomas J Carmody

J Psychiatr Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
Joseph P McEvoy, Matthew Byerly, Robert M Hamer, Rosalie Dominik, Marvin S Swartz

JAMA· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curricula for teaching clinical practice guidelines in US psychiatry residency and child and adolescent fellowship programs: a survey study.
Elizabeth Bannister, Paul Nakonezny, Matthew Byerly

Acad Psychiatry· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subjective quality of life and sexual dysfunction in outpatients with schizophrenia or schizoaffective disorder.
Mark E Bushong, Paul A Nakonezny, Matthew J Byerly

J Sex Marital Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of providing patient-specific electronically monitored antipsychotic medication adherence results on the treatment planning of prescribers of outpatients with schizophrenia.
Paul A Nakonezny, Matthew J Byerly, Amit Pradhan

Psychiatry Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
T Scott Stroup, Matthew J Byerly, Henry A Nasrallah, Neepa Ray, Ahsan Y Khan

Schizophr Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.
Paul A Nakonezny, Carroll W Hughes, Taryn L Mayes, Kathryn H Sternweis-Yang, Betsy D Kennard, Matthew J Byerly

J Child Adolesc Psychopharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Matthew J Byerly, Ronald N Marcus, Quynh-Van Tran, James M Eudicone, Richard Whitehead

Schizophr Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
Matthew J Byerly, Paul A Nakonezny, A John Rush

Psychiatry Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis